292 related articles for article (PubMed ID: 37561524)
1. A novel and robust pyroptosis-related prognostic signature predicts prognosis and response to immunotherapy in esophageal squamous cell carcinoma.
Zhang D; Zhao F; Li J; Qin X; Li S; Niu R
Aging (Albany NY); 2023 Aug; 15(15):7811-7830. PubMed ID: 37561524
[TBL] [Abstract][Full Text] [Related]
2. Construction of a novel pyrotosis-related prognostic model of esophageal square cell carcinoma and determination of the anti-tumor effect of WFDC12.
Zhuang Y; Wang L; Ji C; Sun Y; Shao F
Funct Integr Genomics; 2023 May; 23(2):177. PubMed ID: 37225895
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a prognostic model related to pyroptosis-related genes for esophageal squamous cell carcinoma using bioinformatics analysis.
Zhang W; Zhang P; Jiang J; Peng K; Shen Z; Kang M
J Thorac Dis; 2022 Aug; 14(8):2953-2969. PubMed ID: 36071753
[TBL] [Abstract][Full Text] [Related]
4. Identification of the pyroptosis-related gene signature and risk score model for esophageal squamous cell carcinoma.
Pan M; Wang Y; Wang Z; Shao C; Feng Y; Ding P; Duan H; Ren X; Duan W; Ma Z; Yan X
Aging (Albany NY); 2023 Apr; 15(8):3094-3106. PubMed ID: 37071001
[TBL] [Abstract][Full Text] [Related]
5. A fibroblast-associated signature predicts prognosis and immunotherapy in esophageal squamous cell cancer.
Ren Q; Zhang P; Zhang X; Feng Y; Li L; Lin H; Yu Y
Front Immunol; 2023; 14():1199040. PubMed ID: 37313409
[TBL] [Abstract][Full Text] [Related]
6. Pyroptosis related genes signature predicts prognosis and immune infiltration of tumor microenvironment in hepatocellular carcinoma.
Fang G; Zhang Q; Fan J; Li H; Ding Z; Fu J; Wu Y; Zeng Y; Liu J
BMC Cancer; 2022 Sep; 22(1):999. PubMed ID: 36127654
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive genomic signature of pyroptosis-related genes and relevant characterization in hepatocellular carcinoma.
Wang S; Gao S; Shan L; Qian X; Luan J; Lv X
PeerJ; 2023; 11():e14691. PubMed ID: 36650832
[TBL] [Abstract][Full Text] [Related]
8. A pyroptosis-related gene signature predicts prognosis and immune microenvironment in hepatocellular carcinoma.
Jin Y; Pu X; Ping D; Huang C; Ding G; Cao L
World J Surg Oncol; 2022 Jun; 20(1):179. PubMed ID: 35659304
[TBL] [Abstract][Full Text] [Related]
9. Expression of pyroptosis-related genes are correlated with immune microenvironment and predict prognosis in ESCA.
Shi Y; Yang Q; Tai G; Chen X
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10701-10713. PubMed ID: 37302999
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
Front Immunol; 2021; 12():669750. PubMed ID: 34054840
[TBL] [Abstract][Full Text] [Related]
11. A Pyroptosis-Related Gene Signature Predicts Prognosis and Immune Microenvironment for Breast Cancer Based on Computational Biology Techniques.
Wang Z; Bao A; Liu S; Dai F; Gong Y; Cheng Y
Front Genet; 2022; 13():801056. PubMed ID: 35464869
[TBL] [Abstract][Full Text] [Related]
12. Novel chemokine related LncRNA signature correlates with the prognosis, immune landscape, and therapeutic sensitivity of esophageal squamous cell cancer.
Zhang Z; Wang J; Han W; Zhao L
BMC Gastroenterol; 2023 Apr; 23(1):132. PubMed ID: 37081402
[TBL] [Abstract][Full Text] [Related]
13. A novel defined pyroptosis-related gene signature predicts prognosis and correlates with the tumour immune microenvironment in lung adenocarcinoma.
Chen Z; Ge L; Xu S; Li Q; Zhou L
Sci Rep; 2023 Jun; 13(1):9921. PubMed ID: 37337018
[TBL] [Abstract][Full Text] [Related]
14. The signature of pyroptosis-related gene prognostic and immune microenvironment in adrenocortical carcinoma.
Gao J; Wang D; Yang Q; Tang M; Du J; He L; Liu W
Front Mol Biosci; 2023; 10():1131402. PubMed ID: 36911522
[TBL] [Abstract][Full Text] [Related]
15. Pyroptosis-Related Gene Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Glioma.
Zhang Y; Zhang C; Yang Y; Wang G; Wang Z; Liu J; Zhang L; Yu Y
Front Cell Dev Biol; 2022; 10():862493. PubMed ID: 35547808
[No Abstract] [Full Text] [Related]
16. Single-cell transcriptomics reveals heterogeneity in esophageal squamous epithelial cells and constructs models for predicting patient prognosis and immunotherapy.
Li C; Song W; Zhang J; Luo Y
Front Immunol; 2023; 14():1322147. PubMed ID: 38098487
[TBL] [Abstract][Full Text] [Related]
17. A prognosis model for predicting immunotherapy response of esophageal cancer based on oxidative stress-related signatures.
Guo J; Tong C; Shi J; Li X; Chen X
Oncol Res; 2023; 32(1):199-212. PubMed ID: 38196829
[TBL] [Abstract][Full Text] [Related]
18. A novel fatty acid metabolism-related signature identifies MUC4 as a novel therapy target for esophageal squamous cell carcinoma.
Li S; Liu Z; Chen Q; Chen Y; Ji S
Sci Rep; 2024 May; 14(1):12476. PubMed ID: 38816411
[TBL] [Abstract][Full Text] [Related]
19. Identification of m
Ma Y; Sun Y; Zhao X; Li J; Fu X; Gong T; Zhang X
Sci Rep; 2023 Sep; 13(1):14499. PubMed ID: 37666951
[TBL] [Abstract][Full Text] [Related]
20. A SARS-CoV-2 related signature that explores the tumor microenvironment and predicts immunotherapy response in esophageal squamous cell cancer.
Ren Q; Zhang P; Zhang S; Chen W; Chi H; Wang W; Zhang W; Lin H; Yu Y
Aging (Albany NY); 2023 Oct; 15(19):10501-10523. PubMed ID: 37812215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
